| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Hypertension and Vascular Research Division.Department of Medicine, Henry Ford Hospital, Detroit, Michigan, USA
* To whom correspondence should be addressed. E-mail: mclapointe{at}aol.com;mlapoin1@hfhs.org.
Upon induction of cyclooxygenase-2 (COX-2), neonatal ventricular myocytes (VM) synthesize mainly prostaglandin E2 (PGE2). The biological effects of PGE2 are mediated through four different G-protein-coupled receptor (GPCR) subtypes (EP1-4). We have previously shown that PGE2 stimulates cAMP production and induces hypertrophy of VM. Since the EP4 receptor is coupled to adenylate cyclase and increases in cAMP, we hypothesized that PGE2 induces hypertrophic growth of cardiac myocytes through a signaling cascade involving EP4/cAMP and activation of protein kinase A (PKA). To test this, we used primary cultures of VM and measured 3H-leucine incorporation into total protein. An EP4 antagonist was able to partially block PGE2 induction of protein synthesis and prevented PGE2-dependent increases in cell surface area and activity of the atrial natriuretic factor promoter, two other indicators of hypertrophic growth. Surprisingly, a PKA inhibitor had no effect. In other cell types, G-proteincoupled receptor activation has been shown to transactivate the epidermal growth factor receptor (EGFR), resulting in p42/44 mitogen-activated protein kinase (MAPK) activation and cell growth. Immunoprecipitation of myocyte lysates demonstrated that the EGFR was rapidly phosphorylated by PGE2 in VM and the EP4 antagonist blocked this. In addition, a selective EGFR inhibitor, AG1478, completely blocked PGE2-induced protein synthesis. We also found that PGE2 rapidly phosphorylated p42/44 MAPK, which was inhibited by the EP4 antagonist and by AG1478. Finally, the p42/44 MAPK inhibitor PD98053 (PD, 25 µmol/L) blocked PGE2- induced protein synthesis. Altogether, we believe these are the first data suggesting that PGE2 induce protein synthesis in cardiac myocytes in part via activation of the EP4receptor and subsequent activation of p42/44MAPK. Activation of p42/44 MAPK is independent of the common cAMP/PKA pathway and involves EP4-dependent transactivation of EGFR.
This article has been cited by other articles:
|
|
 |
|
  D. G. Tilley, I.-M. Kim, P. A. Patel, J. D. Violin, and H. A. Rockman {beta}-Arrestin Mediates {beta}1-Adrenergic Receptor-Epidermal Growth Factor Receptor Interaction and Downstream Signaling J. Biol. Chem., July 24, 2009; 284(30): 20375 - 20386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Meyer-Kirchrath, M. Martin, C. Schooss, C. Jacoby, U. Flogel, A. Marzoll, J. W. Fischer, J. Schrader, K. Schror, and T. Hohlfeld Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart Cardiovasc Res, February 1, 2009; 81(2): 310 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Degousee, S. Fazel, D. Angoulvant, E. Stefanski, S.-C. Pawelzik, M. Korotkova, S. Arab, P. Liu, T. F. Lindsay, S. Zhuo, et al. Microsomal Prostaglandin E2 Synthase-1 Deletion Leads to Adverse Left Ventricular Remodeling After Myocardial Infarction Circulation, April 1, 2008; 117(13): 1701 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Yin, G. N. Jones, W. H. Towns II, X. Zhang, E. D. Abel, P. F. Binkley, D. Jarjoura, and L. S. Kirschner Heart-Specific Ablation of Prkar1a Causes Failure of Heart Development and Myxomagenesis Circulation, March 18, 2008; 117(11): 1414 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Arcidiacono, T. Sato, D. Alvarez-Hernandez, J. Yang, M. Tokumoto, I. Gonzalez-Suarez, Y. Lu, Y. Tominaga, J. Cannata-Andia, E. Slatopolsky, et al. EGFR Activation Increases Parathyroid Hyperplasia and Calcitriol Resistance in Kidney Disease J. Am. Soc. Nephrol., February 1, 2008; 19(2): 310 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Qian, P. Harding, Y. Liu, E. Shesely, X.-P. Yang, and M. C. LaPointe Reduced Cardiac Remodeling and Function in Cardiac-Specific EP4 Receptor Knockout Mice With Myocardial Infarction Hypertension, February 1, 2008; 51(2): 560 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Testa, B. Rocca, L. Spath, F. O. Ranelletti, G. Petrucci, G. Ciabattoni, F. Naro, S. Schiaffino, M. Volpe, and C. Reggiani Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents J Appl Physiol, October 1, 2007; 103(4): 1412 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hatazawa, A. Tanaka, M. Tanigami, K. Amagase, S. Kato, Y. Ashida, and K. Takeuchi Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G788 - G797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Bamman Take two NSAIDs and call on your satellite cells in the morning J Appl Physiol, August 1, 2007; 103(2): 415 - 416. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Guo, Z. Xia, J. Jiang, and J. H. McNeill Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1728 - H1736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Schaub and M. A. Hefti The PGE2-Stat3 connection in cardiac hypertrophy Cardiovasc Res, January 1, 2007; 73(1): 3 - 5. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Frias, M. C. Rebsamen, C. Gerber-Wicht, and U. Lang Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy Cardiovasc Res, January 1, 2007; 73(1): 57 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Qian, A. Leung, P. Harding, and M. C. LaPointe PGE2 stimulates human brain natriuretic peptide expression via EP4 and p42/44 MAPK Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1740 - H1746. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
